Related Experiment Video

Updated: Mar 21, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

An audit of HIV treatment outcomes in a UK inner city cohort

E Bird1, I Cormack2, M Rodgers2

  • 1Genitourinary Medicine, Croydon University Hospital, London, UK elspethbird@doctors.org.uk.

International Journal of STD & AIDS
|May 6, 2016
PubMed

Insights

The Croydon HIV cohort in London achieved excellent viral load suppression, exceeding national benchmarks. This demonstrates effective HIV management even in a challenging urban environment.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • HIV infection remains a significant public health concern globally.
  • Effective antiretroviral therapy (ART) is crucial for managing HIV and preventing transmission.
  • Assessing treatment outcomes in diverse patient populations is essential for optimizing care.

Purpose of the Study:

  • To evaluate the demographic characteristics of HIV-infected patients at Croydon University Hospital.
  • To assess viral load suppression rates and treatment outcomes in this specific cohort.
  • To compare the cohort's outcomes with national HIV data.

Main Methods:

  • Retrospective analysis of patient data from Croydon University Hospital.
  • Demographic profiling of the HIV-infected cohort.
  • Calculation and comparison of viral load suppression percentages.

Main Results:

  • The Croydon Cohort demonstrated high rates of viral load suppression: 98.6% <100 copies/mL and 99.0% <200 copies/mL.
  • These outcomes surpass those reported in Public Health England data from 2014 and British HIV Association audit data from 2009.
  • The cohort represents a potentially challenging population in a deprived area of London.

Conclusions:

  • High viral load suppression is achievable in HIV-infected individuals in London, even in socioeconomically deprived areas.
  • The Croydon Cohort's outcomes indicate successful HIV treatment and management strategies.
  • These findings suggest that localized, effective HIV care can outperform national averages.

Keywords:
HIVHIV treatment outcomesantiretroviral therapyauditmedium-sized clinic

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
202
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K